PulmCCM

Share this post
Is your stage III NSCLC patient truly "downstaged" to N0? EUS helpful only if positive
www.pulmccm.org

Is your stage III NSCLC patient truly "downstaged" to N0? EUS helpful only if positive

Oct 2, 2011
Share this post
Is your stage III NSCLC patient truly "downstaged" to N0? EUS helpful only if positive
www.pulmccm.org

So you've referred your patient with stage III non-small cell lung cancer (N2 or N3 mediastinal nodes) to receive neoadjuvant chemoradiation therapy in the hopes of eliminating cancer from the mediastinal nodes, "downstaging" her to a resectable N0 status. How do you re-evaluate the lymph nodes to ensure resection may be curative?

von Bartheld et al retrospectively looked at 58 consecutive patients with N2/N3 stage III NSCLC who received neoadjuvant chemoradiation, and then underwent transesophageal ultrasound fine needle aspiration (EUS-FNA).

EUS-FNA found metastasis in 15 patients (26%). That left 43 who were negative by EUS, and 33 of them underwent mediastinoscopy, of which 58% were positive.

Take-home: EUS-FNA is a good first test in re-analyzing the mediastinal nodes after chemoradiation for stage III N2/N3 NSCLC, because if it's positive you're done. However, its low negative predictive value mean a negative test must be followed up with more invasive sampling.

von Bartheld et al. Transesophageal Ultrasound-Guided Fine-Needle Aspiration for the Mediastinal Restaging of Non-small Cell Lung Cancer.  J Thorac Oncol 2011;6:1510-1515.

Share this post
Is your stage III NSCLC patient truly "downstaged" to N0? EUS helpful only if positive
www.pulmccm.org
Comments
TopNew

No posts

Ready for more?

© 2023 PulmCCM
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing